Archive for August, 2007

Levitra drug interactions

Wednesday, August 29th, 2007

Products containing vardenafil (Levitra) should not be used by individuals who are taking any nitrate medication because combining these products could result in the development of potentially life-threatening low blood pressure.

What LEVITRA does:

Sunday, August 19th, 2007
  • LEVITRA helps increase blood flow to the penis, so it may help men with ED get and keep an erection that lasts long enough to finish having sex. Once a man has completed sexual activity, blood flow to his penis should decrease and his erection should go away
  • LEVITRA has been clinically shown to improve erectile function, even in men who had other health factors, like high cholesterol, high blood pressure, or diabetes
  • LEVITRA provided first-time success and reliable improvement of erection quality for many men, including those with high cholesterol, high blood pressure, or diabetes
  • Men taking LEVITRA reported having harder erections and greater success at maintaining their erections long enough to finish having sex

Levitra - Vardenafil

Thursday, August 9th, 2007

Vardenafil (INN) is a PDE5 inhibitor used in the treatment of erectile dysfunction. It can assist men with this disorder in achieving and maintaining an erection during sexual activity. It is commonly marketed under the trade name Levitra (Bayer AG).

Vardenafil was co-marketed by Bayer Pharmaceuticals and GSK under the trade name Levitra. As of 2005, the co-promotion rights of GSK on Levitra have been “transferred back” to Bayer in many markets outside of the United States. In Italy, Bayer markets the product as Levitra and GSK markets the product as Vivanza. Due to European Union trade rules, parallel imports may result in the Vivanza branded packs being seen alongside Levitra packs in pharmacies in other EU member states.